Center for Cancer Nanotechnology Excellence Focused on Therapy Response
Stanford University CCNE

• Center Home
• Overview
• Projects
• Cores
• Investigators

This Center for Cancer Nanotechnology Excellence focused on therapy response (CCNE-TR) brings together scientists and physicians from Stanford University, University of California Los Angeles (UCLA), Cedars Sinai Medical Center, Fredrick Hutchinson Cancer Center, University of Texas at Austin, Intel Corporation, and General Electric Global Research in a novel proposal to utilize nanotechnology for the benefit of cancer patient management. » Read More

Center Investigators

Sanjiv Sam Gambhir, M.D., Ph.D.
Principal Investigator

[+] More Investigators

For more information about the Center for Cancer Nanotechnology Excellence focused on Therapeutic Response visit our website at: http://mips.stanford.edu/public
/grants/ccne/index.tcl

View all Alliance News

Projects

• Project 1: Magneto-Nano Protein Chip and Multiplex Sorter for Monitoring Tumor Markers
• Project 2: Multiplex Nanotube Based Protein Nano-Arrays for Cancer Research
• Project 3: Multiparameter Nanoparticle Detection of Phosphoproteins
• Project 4: Proteomic Predictors of Clinical Outcome of Targeted Therapies in Prostate Cancer
• Project 5: Biological Modification of Quantum Dots for in vivo Imaging
• Project 6: Mouse Cancer Models for Integrated Tissue/Serum Proteomics and Molecular Imaging

Cores

• Stanford Nanocharacterization Laboratory Core
• Service Facility for Fabricated Nanostructures Core
• Bioinformatics and Biostatistics Resource Core